Tarsus Pharmaceuticals, Inc. - COM (TARS)

Historical Portfolio Holders from Q4 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
36.8 M
Holdings value Q1 2024
$1.34 B
Value change Q1 2024
+$242 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
152
Number of buys Q1 2024
101
Number of sells Q1 2024
-39
Average buys Q1 2024 %
+0.003%
Average sells Q1 2024 %
-0.002%
CUSIP
87650L103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 36.8 M $1.34 B +$242 M $36.35 152
2023 Q4 30.2 M $611 M +$11.5 M $20.25 113
2023 Q3 29.3 M $520 M +$139 M $17.77 105
2023 Q2 21.4 M $387 M +$39.2 M $18.07 92
2023 Q1 20.1 M $252 M -$6.02 M $12.57 73
2022 Q4 20.5 M $301 M +$14 M $14.66 65
2022 Q3 19.8 M $339 M +$9.47 M $17.12 71
2022 Q2 19.4 M $283 M +$98.1 M $14.60 66
2022 Q1 13.2 M $222 M +$2.27 M $16.82 48
2021 Q4 13.1 M $294 M +$4.71 M $22.50 42
2021 Q3 12.4 M $266 M -$13 M $21.55 43
2021 Q2 12.5 M $363 M -$6.9 M $28.98 42
2021 Q1 12.8 M $410 M -$214 K $32.23 41
2020 Q4 12.8 M $524 M +$524 M $41.33 39